A Study of Oral Lorlatinib in Patients With Relapsed ALK Positive Lymphoma
Clinical trial NCT03505554 · COMPLETED
Trial details
- NCT number
- NCT03505554
- Sponsor
- University of Milano Bicocca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-28
- Primary completion
- 2025-12-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.